Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Blood glucose level modulation via low-glycemic carbohydrate blend" refers to the strategy of managing postprandial (after eating) increases in blood sugar by consuming foods that contain carbohydrates with a *low glycemic index* (GI). The GI ranks foods according to how quickly their carbohydrates are digested and absorbed into the bloodstream as glucose. Foods with lower GI values (<55) cause slower rises in blood sugar compared to high-GI foods (>70), which can help maintain more stable insulin levels and may reduce risks associated with type 2 diabetes and cardiovascular disease. This approach does not refer to any single biological molecule or druggable target but rather represents an evidence-based nutritional intervention for metabolic health.[1][2][3][4][5][6]
Not applicable; however, the mechanism by which low-GI foods modulate blood glucose involves slower digestion and absorption of carbohydrates, leading to reduced spikes in postprandial blood sugar and insulin demand[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood glucose level modulation via low-glycemic carbohydrate blend.